PHARMACORP RX INC

Pharmacorp Rx (PCRX.V) stays flat at CAD 0.40 amid cautious market sentiment; watch for upcoming clinical milestones and funding news that could shift its outlook.

Pharmacorp Rx (PCRX.V) trades flat on TSX Venture, but a new pharmacist‑equity strategy unveiled at the Planet MicroCap conference could spark growth. Discover how this niche model may reshape community pharmacy investing.

Pharmacorp Rx (PCRX.V) slid 1.84 % to CAD 0.40, trading below its 20‑day average and 52‑week low while Canadian biotech shares mixed; see latest market data.